Current concepts in thromboprophylaxis following hip fracture

Current Orthopaedics

Volumn 17, Issue 3, 2003, Pages 215-222

  Warwick, D ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXTRAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; WARFARIN;

ANTICOAGULATION; BIOMECHANICS; DEEP VEIN THROMBOSIS; HEMOSTASIS; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0038127239     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-0890(03)00043-4     Document Type: Article

References (73)

1. Audit Commission. United they Stand - Co-ordinating Care for Elderly Patients with Hip Fracture. 2001.
2. van Balen R, Steyerberg E W, Polder J J, Ribbers T L, Habbema J D, Cools H J. Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop 2001; 390: 232-243.
3. Zuckerman J D. Hip fracture. N Engl J Med 1996; 334: 1519-1525.
4. Shah M R, Aharonoff G B, Wolinsky P, Zuckerman J D, Koval K J. Outcome after hip fracture in individuals ninety years of age and older. J Orthop Trauma 2001; 15: 34-39.
5. Lichtblau S. Hip fracture. Surgical decisions that affect medical management. Geriatrics 2000; 55: 50-56.
6. Keene G S, Parker M J, Pryor G A. Mortality and morbidity after hip fractures. BMJ 1993; 307: 1248-1250.
7. Warwick D J, Martin A, Glew D, Bannister G. Measurement of femoral vein blood flow during total hip replacement. J Bone Joint Surg 1994; 76B: 918-921.
8. McNally M A, Mollan R A B. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg 1993; 75B: 640-644.
9. Ginsberg J S, Brill-Edwards P, Panju A Patel A. et al. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery. Thromb Haemost 1995; 74: 602-605.
10. Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery. Thromb Haemost 1997; 77: 267-269.
11. Dahl O E, Pedersen T, Kioerrulf P, Westvik A B, Lund P, Arnesen H. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 1993; 70: 451-458.
12. Erith M H, Weber J G, Abel M D. Cemented versus uncemented total hip arthroplasty - embolism, haemodynamics and intrapulmonary shunting. Mayo Clin Proc 1992; 67: 1066-1074.
13. Hefley Jr. F G, Nelson C L, Puskarich-May C L. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip. J Bone Joint Surg Am 1996; 78: 581-583.
14. Morrison R S, Chassin M R, Siu A L. The medical consultant's role in caring for patients with hip fracture. Ann Intern Med 1998; 128(12 Part 1): 1010-1020.
15. Gardner A M N, Fox R H. The return of blood to the heart: venous pumps in health and disease. London: John Libby and Co., 2001.
16. International Consensus Statement. Prevention of venous thromboembolism. Int Angiol 2001; 20: 1-37.
17. Geerts W H, Heit J A, Clagett G P, Pineo G F, Colwell C W, Anderson F. A, Wheeler H. B. Prevention of venous thromboembolism. Chest 2001; 119: 132S-175S.
18. Warwick D J, Samama M M. The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement. J Bone Joint Surg 2000; 82B: 480-482.
19. Moser K M, LeMoine J R. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med 1981; 94: 439-444.
20. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Points to consider on clinical investigation of medicinal products for prophylaxis of intra- and post-operative venous thromboembolic risk. CPMP/ EWP/707/98. 2000.
21. Aharonoff G B, Koval K J, Skovron M L, Zuckerman J D. Hip fractures in the elderly: predictors of one year mortality. J Orthop Trauma 1997; 11: 162-165.
22. Schurch M A, Rizzoli R, Mermillod B, Vasey H, Michel J P, Bonjour J P. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 1996; 11: 1935-1942.
23. Todd C J, Freeman C J, Camilleri-Ferrante C et al. Differences in mortality after fracture of hip: the east anglian audit. BMJ 1995; 310: 904-908.
24. Schroder I M, Andreassen M. Autopsy-verified major pulmonary embolism after hip fracture. Clin Orthop 1993; 293: 196-203.
25. Perez J V, Warwick D J, Case C P, Bannister G C. Death after proximal femoral fracture - an autopsy study. Injury 1995; 26: 237-240.
26. PEP Trial Collaborative Group. Prevention of pulmonary embolism, deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 2000; 355: 1295-1302.
27. Haas S K, Wolf H, Encke A, Fareed J. Prevention of fatal postoperative pulmonary embolism by low molecular weight heparin - a double blind comparison of certoparin and unfractionated heparin. Thromb Haemost 1999; 82.
28. Prins M, Hirsh J. A Comparison of general anaesthesia and regional anaesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical review. Thromb Haemost 1990; 64: 497-500.
29. Davis F M, Laurenson V G, Gillespie W J, Foate J, Seagar A D. Leg blood flow during total hip replacement under spinal or general anaesthesia. Anaesth Intensive Care 1989; 17: 136-143.
30. Modig J, Borg T, Bagge L, Saldeen T. Role of extradural and of general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 55: 625-629.
31. Urwin S C, Parker M J, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000; 84: 450-455.
32. Parker M J, Urwin S C, Handoll H H, Griffiths R. General versus spinal/epidural anaesthesia for surgery for hip fractures in adults. Cochrane Database Syst Rev 2000; CD000521.
33. Lawrence D, Kakkar V V. Graduated static external compression of the lower limb: a physiological assessment. Br J Surg 1980; 676: 119-121.
34. Best A J, Williams S, Crozier A, Bhatt R, Gregg P J, Hui A C W. Graded compression stockings in elective orthopaedic surgery. J Bone Joint Surg 2000; 82B: 116-118.
35. Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 1999; 86: 992-1004.
36. Wells P S, Lensing A W A, Hirsh J. Graduated compression stockings in the prevention of post-operative venous thromboembolism: a meta-analysis. Arch Intern Med 1994; 154: 67-72.
37. Comerota A J, Chouhan V, Harada R N et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226: 306-313.
38. Stannard J P, Harris R M, Bucknell A L, Cossi A, Ward J, Arington E D. Prophylaxis of deep vein thrombosis after total hip arthroplasty using intermittent compression of the plantar venous plexus. Am J Orthop 1996; 2: 127-134.
39. Fordyce M, Ling R S M. A venous foot pump reduces thrombosis after hip replacement. J Bone Joint Surg 1992; 74B: 45-49.
40. Santori F S, Vitullo A, Stopponi M, Santori N, Ghera S. Prophylaxis against deep vein thrombosis in total hip replacement: comparison of heparin and foot impulse pump. J Bone Joint Surg 1994; 76B: 579-583.
41. Warwick D J, Harrison J, Glew D, Mitcdhelmore A, Peters T, Donovan J. Comparison of the use of a foot pump with the use of low molecular weight heparin for the prevention of deep vein thrombosis after total hip replacement. J Bone Joint Surg 1998; 80A: 1158-1166.
42. Stranks G J, McKenzie N A, Grover M L, Fail T. The AV impulse system reduces deep vein thrombosis and swelling after hemiarthroplasty for hip fracture. J Bone Joint Surg 1992; 74B: 775-778.
43. Anglen J O, Goss K, Edwards J, Huckfeldt R E. Foot pump prophylaxis for deep venous thrombosis: the rate of effective usage in trauma patients. Am J Orthop 1998; 27: 580-582.
44. Fleming P, Fitgerald P, Devitt A, Rice J, Murray P. The effect of the position of the limb on venous impulse foot pumps. J Bone Joint Surg (Br) 2000; 82B: 433-434.
45. Warwick D J, Pandit H, Sheale S, Sulkin T. Venous foot pumps: should graduated stockings be used? J Arthoplasty; in press.
46. Hull R D, Rascob G E, Gent M et al. Effectiveness of intermittent pneumatic compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990; 263: 2313-2317.
47. Hartman J T, Pugh J L, Smith R D, Robertson W W, Yost R P, Janssen H F. Cyclic sequential compression of the lower limb in prevention of deep vein thrombosis. J Bone Joint Surg 1982; 64A: 1059-1062.
48. Gallus A, Raman K, Darby T. Venous thrombosis after elective hip replacement. The influence of preventive intermittent calf compression and of surgical technique. Br J Surg 1993; 70: 17-19.
49. Comerota A J, Catz M L, White J J. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992; 164: 265-266.
50. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1173.
51. Monreal M, Lafoz E, Navarro A. A prospective double blind trial of a low molecular weight heparin once daily compared with conventional low dose heparin three times daily to prevent venous thromboembolism and venous thrombosis in patients with hip fracture. J Trauma 1989; 29: 873-875.
52. Moskowitz P A, Ellenberg S S, Feffer H L, Kenmore P I, Nevaiser R J, Rubin B E, Varma V M. Low dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg 1978; 60A: 1065-1070.
53. Leizorovicz A, Haugh M C, Chapuis F R, Samama M M, Boissel J P. Low molecular weight heparin in the prevention of peri-operative thrombosis. Br Med J 1992; 305: 913-920.
54. Bergqvist D, Kettunen K, Fredin H et al. Thromboprophylaxis in patients with hip fractures: a prospective randomised, comparative study between ORG 10172 and dextran 70. Surgery 1991; 109: 617-622.
55. Bergqvist E, Bergqvist D, Bronge A, Dahlgren S, Lindquist B. An evaluation of early thrombosis prophylaxis following fracture of the femoral neck: a comparison between dextran and dicoumarol. Acta Chir Scand 1972; 138: 689-693.
56. Bronge A, Dahlgren S, Lindquist B. Prophylaxis against thrombosis in femoral neck fractures - a comparison between dextran 70 and dicoumarol. Acta Chir Scand 1971; 137: 29-35.
57. Borgstrom S, Greitz T, van der Linden W. Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of femur; a controlled clinical trial using venous phlebography. Acta Chir Scand 1965; 129: 500-508.
58. Gerhart T N, Yett H S, Robertson L K, Lee M A, Smith M, Salzman E W. Low molecular weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip. A prospective randomised trial. J Bone Joint Surg 1991; 73A: 494-502.
59. Hamilton J W, Crawford J S, Gardiner J H, Wiley A M. Venous thrombosis in patients with fracture of the upper end of the femur: a phlebographic study of the effect of prophylactic anticoagulation. J Bone Joint Surg 1970; 52B: 268-289.
60. Powers P J, Gent M, Jay R M, Julian D H, Turpie A G, Leine M, Hirsh J. A randomised trial of less intense warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 1989; 149: 771-774.
61. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-246.
62. Sors H, Meyer G. Place of aspirin in prophylaxis of venous thromboembolism. Lancet 2000; 355: 1288-1289.
63. Cohen A, Quinlan D. PEP Trial. Pulmonary embolism prevention. Lancet 2000; 356: 241-247.
64. Borris L C, Lassen M R, Poulson K A, Jensen H P. Thromboembolic complications after hip fracture-prophylaxis with low molecular weight vs unfractionated heparin. Thromb Haemost 1995; 73: 104.
65. Barsotti J, Gruel Y, Rosset P. Comparitive double blind study of two dosage regimens of low molecular weight heparin in elderly patients after fracture neck of femur. J Orthop Trauma 1990; 4: 371-375.
66. Jorgensen P S, Strandberg C, Wille-Jorgensen P. Early preoperative thromboprophylaxis with Klexane in hip fracture surgery: a placebo controlled study. Clin Appl Thromb Haemost 1998; 4: 140-142.
67. The TIFTED Study Group. Thromboprophylaxis in hip fracture surgery: a pilot study comparing danparoid, enoxaparin and dalteparin. Haemostasis 1999; 29: 310-317.
68. Eriksson B I, Bauer K A, Lassen M R, Turpie A G G. The Steering Committee of the Pentasaccharide in Hip. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345: 1298-1304.
69. Bergqvist D, Benoni G, Biorgell O. Low molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 1525-1531.
70. Dahl O, Andreassen G, Aspelin T et al. Prolonged prophylaxis following hip replacement surgery - results of a double blind, prospective, randomised placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
71. Hull R D, Pineo G F, Francis C et al. Low molecular weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients. Arch Inten Med 2000; 160: 2208-2215.
72. Planes A, Vochelle C, Darmon J Y. Risk of deep venous thrombosis after discharge in patients having undergone total hip replacement: double blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-228.
73. Spiro T E. A double blind multi centre clinical trial comparing long termenoxaparin and placebo treatments in the prevbention of venous thromboembolic disease after hip and knee replacement surgery. Blood 1997; 90: 295a (Abstract).